Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology

Summary

The aim of the registry is to evaluate Chinese real-World clinical outcomes in patients With AF using the WATCHMAN left Atrial appendage closure technology

Conditions

• Non-valvular Atrial Fibrillation

Interventions

DEVICE

WATCHMAN LAA occluder

WATCHMAN LAA occluder

Sponsors & Collaborators

• Beijing Tiantan Hospital

  collaborator OTHER

• Beijing Hospital

  collaborator OTHER_GOV

• the PLA General Hospital

  collaborator UNKNOWN

• Beijing Chao Yang Hospital

  collaborator OTHER

• Peking University First Hospital

  collaborator OTHER

• Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

  collaborator OTHER

• Shanghai 10th People's Hospital

  collaborator OTHER

• Changhai Hospital

  collaborator OTHER

• Dongfang Hospital Affiliated to Tongji University

  collaborator OTHER

• Shanghai 6th People's Hospital

  collaborator OTHER

• Ruijin Hospital

  collaborator OTHER

• Shanghai Thoracic Hospital

  collaborator UNKNOWN

• Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

  collaborator OTHER

• Shenzhen Sun Yat-sen Cardiovascular Hospital

  collaborator OTHER

• Tianjin Medical University General Hospital

  collaborator OTHER

• Southwest Hospital, China

  collaborator OTHER

• Shengjing Hospital

  collaborator OTHER

• The First Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• Central Hospital of Dalian

  collaborator UNKNOWN

• General Hospital of Shenyang Military Region

  collaborator OTHER

• Qilu Hospital of Shandong University

  collaborator OTHER

• The Second Hospital of Hebei Medical University

  collaborator OTHER

• Shanxi Cardiovascular Hospital

  collaborator OTHER

• People's Hospital of Taizhou

  collaborator UNKNOWN

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  collaborator OTHER

• Second Affiliated Hospital, School of Medicine, Zhejiang University

  collaborator OTHER

• Ningbo No. 1 Hospital

  collaborator OTHER

• Sir Run Shaw Hospital

  collaborator UNKNOWN

• First Affiliated Hospital of Wenzhou Medical University

  collaborator OTHER

• Second Affiliated Hospital of Wenzhou Medical University

  collaborator OTHER

• Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

  collaborator OTHER

• Wuhan Asia Heart Hospital

  collaborator OTHER

• First Affiliated Hospital Xi'an Jiaotong University

  collaborator OTHER

• General Hospital of Ningxia Medical University

  collaborator OTHER

• Sichuan Provincial People's Hospital

  collaborator OTHER

• West China Hospital

  collaborator OTHER

• ZhuHai Hospital

  collaborator OTHER

• First Affiliated Hospital of Xinjiang Medical University

  collaborator OTHER

• Xijing Hospital

  lead OTHER

Principal Investigators

• Ling Tao · Xijing Hospital

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Max Age

100 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-04-20

Primary Completion

2021-04-20

Completion

2024-04-20

Countries

• China

Study Locations